References

Scottish referral guidelines for suspected cancer
Centre for Sustainable Delivery
  1. Public Health Scotland (2024). Cancer incidence in Scotland to December 2022, https://publichealthscotland.scot/publications/cancer-incidence-in-scotland/cancer-incidence-in-scotland-to-december-2022/
  2. Public Health Scotland (2025). General practice list size and demographics information – January 2025, https://publichealthscotland.scot/publications/general-practice-list-size-and-demographics-information/
  3. Scotland's Census. Scotland's Census 2022 - Rounded population estimates
  4. Public Health Scotland (2023). Cancer incidence in Scotland to December 2021, https://publichealthscotland.scot/publications/cancer-incidence-in-scotland/cancer-incidence-in-scotland-to-december-2021/ 
  5. Public Health Scotland (2023). Cancer staging data, https://publichealthscotland.scot/publications/cancer-staging-data/2022-cancer-staging-data-28-november-2023/
  6. University of Glasgow and University of Edinburgh (2023). Tackling the inverse care law in Scottish General Practice. https://www.health.org.uk/reports-and-analysis/reports/tackling-the-inverse-care-law-in-scottish-general-practice
  7. Lloyd, T., Hounsome, L., Mehay, A., Mee, S., Verne, J., & Cooper, A. (2015). Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008-2010. BMC medicine, 13, 171. https://doi.org/10.1186/s12916-015-0405-5
  8. Moore SF, Price SJ, Chowienczyk S, Bostock J, Hamilton W. (2021). The impact of changing risk thresholds on the number of people in England eligible for urgent investigation for possible cancer: an observational cross-sectional study. Br J Cancer.125(11):1593-7 https://doi.org/10.1038/s41416-021-01541-4
  9. Moore, S.F., Price, S.J., Bostock, J., Neal, R.D. and Hamilton, W. (2023). Incidence of ‘low-risk but not no-risk’ features of cancer prior to high-risk feature occurrence: An observational cohort study in primary care. Cancers 15(15), p.3936. https://doi.org/10.3390/cancers15153936
  10. Corso, G., Gandini, S., D’Ecclesiis, O., Mazza, M., Magnoni, F., Veronesi, P., et al. (2023). Risk and incidence of breast cancer in transgender individuals: a systematic review and meta-analysis. European Journal of Cancer Prevention, 32(3), 207-214. https://doi.org/10.1097/CEJ.0000000000000784
  11. Brown, K. F., Rumgay, H., Dunlop, C., Ryan, M., Quartly, F., Cox, A., et al. (2018). The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. British journal of cancer, 118(8), 1130–1141. https://doi.org/10.1038/s41416-018-0029-6
  12. Smith, C. F., Drew, S., Ziebland, S., & Nicholson, B. D. (2020). Understanding the role of GPs' gut feelings in diagnosing cancer in primary care: a systematic review and meta-analysis of existing evidence. The British journal of general practice 70(698), e612–e621.  https://doi.org/10.3399/bjgp20X712301  
  13. Donker, G. A., Wiersma, E., van der Hoek, L., & Heins, M. (2016). Determinants of general practitioner's cancer-related gut feelings-a prospective cohort study. BMJ open, 6(9), e012511. https://doi.org/10.1136/bmjopen-2016-012511
  14. Nicholson B. D., Hamilton W., Koshiaris C., Oke J. L., Hobbs F. D. R. , Aveyard P. The association between unexpected weight loss and cancer diagnosis in primary care: a matched cohort analysis of 65,000 presentations. Br J Cancer. 2020 Jun;122(12):1848-1856. https://doi.org/10.1038/s41416-020-0829-3.
  15. Nicholson, B. D., Thompson, M. J., Hobbs, F. D., Nguyen, M., McLellan, J., Green, B., et al. Measured weight loss as a precursor to cancer diagnosis: retrospective cohort analysis of 43,302 primary care patients, Journal of Cachexia, Sarcopenia and Muscle, 13, 2492–2503, https://doi.org/10.1002/jcsm.13051
  16. Price, S. J., Gibson, N., Hamilton, W. T., King, A., & Shephard, E. A. (2022). Intra-abdominal cancer risk with abdominal pain: a prospective cohort primary care study. The British journal of general practice: the journal of the Royal College of General Practitioners, 72(718), e361–e368. https://doi.org/10.3399/BJGP.2021.0552
  17. Bailey, S. E., Ukoumunne, O. C., Shephard, E. A., & Hamilton, W. (2017). Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data. The British journal of general practice: the journal of the Royal College of General Practitioners, 67(659), e405–e413. https://doi.org/10.3399/bjgp17X691109
  18. Gold, L.C., Macpherson, I., Nobes, J.H., Dow, E., Furrie, E., Jamieson, S., Dillon, F. (2022). Thrombocytosis and abnormal liver enzymes: A trigger for investigation of underlying malignancy. PLoS ONE 17(4): e0267124. https://doi.org/10.1371/journal.pone.0267124
  19. Cancer Research UK. Cancer Statistics Data Hub. Accessed November 2024 https://crukcancerintelligence.shinyapps.io/CancerStatsDataHub/, https://crukcancerintelligence.shinyapps.io/EarlyDiagnosis/.
  20. Penfold, C., Joannides, A. J., Bell, J., & Walter, F. M. (2017). Diagnosing adult primary brain tumours: can we do better? The British journal of general practice: the journal of the Royal College of General Practitioners, 67(659), 278–279. https://doi.org/10.3399/bjgp17X691277
  21. Scott, S. E., Penfold, C., Saji, S., Curtis, S., Watts, C., Hamilton, W., et al. (2019). 'It was nothing that you would think was anything': Qualitative analysis of appraisal and help seeking preceding brain cancer diagnosis. PloS one, 14(3), e0213599. https://doi.org/10.1371/journal.pone.0213599
  22. Ozawa, M., Brennan, P. M., Zienius, K., Kurian, K. M., Hollingworth, W., Weller, D., et al. (2019). The usefulness of symptoms alone or combined for general practitioners in considering the diagnosis of a brain tumour: a case-control study using the clinical practice research database (CPRD) (2000-2014). BMJ open, 9(8), e029686. https://doi.org/10.1136/bmjopen-2019-029686
  23. Zienius, K., Hewins, W., Summers, D., McKinlay, L., Brennan, P., Porteous, L., Grant, R. (2022). Testing Semantic Verbal Fluency (SVFT) in patients with headache suspicious of cancer helps predict those with tumour on imaging. Neuro-Oncology, 24, Supplement_2, ii28–ii29. https://doi.org/10.1093/neuonc/noac174.093
  24. Public Health Scotland, Detect Cancer Early Staging Data. Summarised by Cancer Research UK, Early Diagnosis Data Hub. Accessed November 2024. https://crukcancerintelligence.shinyapps.io/EarlyDiagnosis/
  25. Cancer Research UK, Breast cancer risk. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/risk-factors 
  26. Román, M., Hofvind, S., von Euler-Chelpin, M., & Castells, X. (2019). Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: joint analysis of three national cohorts. British journal of cancer, 120(2), 269–275. https://doi.org/10.1038/s41416-018-0358-5
  27. de Blok, C. J. M., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M. A. (2019). Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands BMJ, 365 https://doi.org/10.1136/bmj.l1652
  28. Jones, C. E., Maben, J., Lucas, G., Davies, E. A., Jack, R. H., & Ream, E. (2015). Barriers to early diagnosis of symptomatic breast cancer: a qualitative study of Black African, Black Caribbean, and White British women living in the UK. BMJ open, 5(3), e006944. https://doi.org/10.1136/bmjopen-2014-006944
  29. Scottish Cancer Registry (SMR06) - Staging by deprivation data: https://publichealthscotland.scot/media/20137/staging_by_deprivation_2021.xlsx
  30. Massat NJ, Douglas E, Waller J, Wardle J, Duffy SW. Variation in cervical and breast cancer screening coverage in England: a cross-sectional analysis to characterise districts with atypical behaviour. BMJ Open. 2015; 5:(7) https://doi.org/10.1136/bmjopen-2015-007735
  31. Public Health Scotland (2024). Endometrial cancer Quality Performance Indicators, https://publichealthscotland.scot/publications/endometrial-cancer/endometrial-cancer-quality-performance-indicators-patients-diagnosed-from-october-2020-to-september-2023/
  32. Leis, M., Singh, A., Li, C., Ahluwalia, R., Fleming, P., & Lynde, C. W. (2022). Risk of vulvar squamous cell carcinoma in lichen sclerosus and lichen planus: A systematic review. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 44(2), 182–192. https://doi.org/10.1016/j.jogc.2021.09.023
  33. Funston, G., O'Flynn, H., Ryan, N. A. J., Hamilton, W., & Crosbie, E. J. (2018). Recognizing gynecological cancer in primary care: Risk factors, Red flags, and referrals. Advances in therapy, 35(4), 577–589. https://doi.org/10.1007/s12325-018-0683-3
  34. Arora T, Mullangi S, Vadakekut ES. Epithelial ovarian cancer. [Updated 2024 May 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK567760/
  35. Jones, E. R., O’Flynn, H., Njoku, K., & Crosbie, E. J. Detecting endometrial cancer. The Obstetrician and Gynaecologist. 23(2), 103-122. April 2021 https://doi.org/10.1111/tog.12722
  36. Morrison, J., Baldwin, P., Hanna, L., Andreou, A., Buckley, L., Durrant, L., et al. British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: An update on recommendations for practice 2023, European Journal of Obstetrics & Gynecology and Reproductive Biology. Volume 292, 2024, Pages 210-238. https://doi.org/10.1016/j.ejogrb.2023.11.013
  37. Howell, D. A., Warburton, F., Ramirez, A. J., Roman, E., Smith, A. G., & Forbes, L. J. (2015). Risk factors and time to symptomatic presentation in leukaemia, lymphoma, and myeloma. British journal of cancer, 113(7), 1114–1120. https://doi.org/10.1038/bjc.2015.311
  38. Delon C, Brown KF, Payne NWS, Kotrotsios Y, Vernon S, Shelton J. Differences in cancer incidence by broad ethnic group in England, 2013-2017. Br J Cancer. 2022 Jun; 126(12):1765-1773. https://doi.org/10.1038/s41416-022-01718-5.
  39. Stern, S., Chaudhuri, S., Drayson, M., Henshaw, S., Karunanithi, K., Willis, F., & Haemato-Oncology Task Force of the British Society for Haematology and the UK Myeloma Forum (2023). Investigation and management of the monoclonal gammopathy of undetermined significance: A British Society for Haematology Good Practice Paper. British journal of haematology, 202(4), 734–744. https://doi.org/10.1111/bjh.18866
  40. Koshiaris, C., Van den Bruel, A., Oke, J. L., Nicholson, B. D., Shephard, E., Braddick, M., and Hamilton, W. (2018). Early detection of multiple myeloma in primary care using blood tests: a case-control study in primary care. The British journal of general practice: the journal of the Royal College of General Practitioners, 68(674), e586–e593. https://doi.org/10.3399/bjgp18X698357
  41. Ravaghi, V., Durkan, C., Jones, K., Girdler, R., Mair-Jenkins, J., Davies, G., et al. (2020). Area-level deprivation and oral cancer in England 2012-2016. Cancer epidemiology, 69, 101840. https://doi.org/10.1016/j.canep.2020.101840
  42. Ingarfield , K., McMahon, A.D., Douglas, C.M., Savage, A., MacKenzie , K. and Conway, D.I. (2018). Inequality in the survival of patients with head and neck cancer in Scotland. Frontiers in Oncology, 8, 673. https://doi.org/10.3389/fonc.2018.00673
  43. Ingarfield, K., McMahon, A. D., Hurley, K., Toms, S., Pring, M., Thomas, S. J., et al. (2021). Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort study. Head & neck, 43(4), 1252–1270. https://doi.org/10.1002/hed.26589
  44. NDRS, Cancer Routes to Diagnosis, https://nhsd-ndrs.shinyapps.io/routes_to_diagnosis/ accessed November 2024
  45. Tucker, M. A., Jones, P. H., Boice, J. D., Jr, Robison, L. L., Stone, B. J., Stovall, M., et al. (1991). Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer research, 51(11), 2885–2888. https://pubmed.ncbi.nlm.nih.gov/1851664/
  46. Tikka, T., Kavanagh, K., Lowit, A., Jiafeng, P., Burns, H., Nixon, I. J., et al. (2020). Head and neck cancer risk calculator (HaNC-RC)-V.2. Adjustments and addition of symptoms and social history factors. Clinical otolaryngology: official journal of ENT-UK; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 45(3), 380–388. https://doi.org/10.1111/coa.13511
  47. Bailey, J. A., Morton, A. J., Jones, J., Chapman, C. J., Oliver, S., Morling, J. R., et al. (2023). Sociodemographic variations in the uptake of faecal immunochemical tests in primary care: a retrospective study. The British journal of general practice: the journal of the Royal College of General Practitioners, 73(736), e843–e849. https://doi.org/10.3399/BJGP.2023.0033
  48. Mitchell, E. D., Pickwell-Smith, B., & Macleod, U. (2015). Risk factors for emergency presentation with lung and colorectal cancers: a systematic review. BMJ open, 5(4), e006965. https://doi.org/10.1136/bmjopen-2014-006965
  49. Franklyn, J., Lomax, J., Labib, P., Baker, A., Hosking, J., Moran, B., and Smolarek, S. (2022). Colorectal cancer outcomes determined by mode of presentation: analysis of population data in England between 2010 and 2014. Techniques in coloproctology, 26(5), 363–372. https://doi.org/10.1007/s10151-022-02574-4
  50. Herbert, A., Rafiq, M., Pham, T. M., Renzi, C., Abel, G. A., Price, S., et al. (2021). Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study. PLoS medicine, 18(8), e1003708. https://doi.org/10.1371/journal.pmed.1003708
  51. Astin, M., Griffin, T., Neal, R. D., Rose, P., & Hamilton, W. (2011). The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. The British journal of general practice: the journal of the Royal College of General Practitioners, 61(586), e231–e243. https://doi.org/10.3399/bjgp11X572427
  52. Hamer-Kiwacz, S., Berntsson, H., Galloway, G. (2024). Barriers and facilitators to faecal immunochemical testing in symptomatic populations: a rapid systematic scoping review and gap analysis. J Eval Clin Pract. 1-9. https://doi:10.1111/jep.14120
  53. Cancer Research UK, Lung cancer mortality statistics, Accessed November 2024
  54. Newsom-Davis T. (2017). The route to diagnosis: emergency presentation of lung cancer. Lung cancer management, 6(2), 67–73. https://doi.org/10.2217/lmt-2017-0004
  55. Mitchell, E. D., Pickwell-Smith, B., & Macleod, U. (2015). Risk factors for emergency presentation with lung and colorectal cancers: a systematic review. BMJ open, 5(4), e006965. https://doi.org/10.1136/bmjopen-2014-006965
  56. Cancer Research UK. Asbestos and other risks of mesothelioma. Accessed November 2024, https://www.cancerresearchuk.org/about-cancer/mesothelioma/risks-causes
  57. Hamilton, W., Peters, T.J., Round, A., & Sharp, D. (2005). What are the clinical features of lung cancer before the diagnosis is made? A population-based case-control study. BMJ Thorax, 60(12), 1059-1065 https://doi.org/10.1136/thx.2005.045880
  58. ESMO (2024). “Families” and List of Rare Cancers [Internet]. ESMO
  59. Cancer Research UK, Types of bone cancer, https://www.cancerresearchuk.org/about-cancer/bone-cancer/types, Accessed November 2024
  60. Younger, E., Husson, O., Bennister, L., Whelan, J., Wilson, R., Roast, A., et al. (2018). Age-related sarcoma patient experience: results from a national survey in England. BMC cancer, 18(1), 991. https://doi.org/10.1186/s12885-018-4866-8
  61. Bacon, A., Wong, K., Fernando, M. S., Rous, B., Hill, R. J. W., Collins, S. D., et al. (2023). Incidence and survival of soft tissue sarcoma in England between 2013 and 2017, an analysis from the National Cancer Registration and Analysis Service. International journal of cancer, 152(9), 1789–1803. https://doi.org/10.1002/ijc.34409
  62. Cancer Research UK. Lipoma. https://www.cancerresearchuk.org/about-cancer/other-conditions/lipoma, Accessed February 2025
  63. Fidler, M. M., Reulen, R. C., Winter, D. L., Allodji, R. S., Bagnasco, F., Bárdi, E., et al. (2018). Risk of Subsequent Bone Cancers Among 69 460 Five-year survivors of childhood and adolescent cancer in Europe. Journal of the National Cancer Institute, 110(2) https://doi.org/10.1093/jnci/djx165
  64. Teepen, J. C., van Leeuwen, F. E., Tissing, W. J., van Dulmen-den Broeder, E., van den Heuvel-Eibrink, M. M., van der Pal, et al. & DCOG LATER Study Group (2017). Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER study cohort: Role of chemotherapy. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 35(20), 2288–2298. https://doi.org/10.1200/JCO.2016.71.6902
  65. Types | Skin cancer | Cancer Research UK [Internet]. Available from: https://www.cancerresearchuk.org/about-cancer/skin-cancer/types
  66. Caudill, J, Thomas, J.E. and Burkhart, C.G. (2022). ‘The risk of metastases from squamous cell carcinoma of the skin’ in International Journal of Dermatology 62(4). https://doi.org/10.1111/ijd.16164
  67. Ascott, A., van Bodegraven, B., Vernon, S., Orteu, C. H., & Venables, Z. C. (2023). The geographical variation of melanoma, basal and squamous cell carcinoma in England. The British journal of dermatology, 189(1), 142–144. https://doi.org/10.1093/bjd/ljad100
  68. NDRS, Urgent suspected cancer referrals - NDRS (digital.nhs.uk), Accessed November 2024
  69. Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Abeni, D., Boyle, P., & Melchi, C. F. (2005). Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. European journal of cancer (Oxford, England: 1990), 41(1), 28–44. https://doi.org/10.1016/j.ejca.2004.10.015
  70. Burton, A., Balachandrakumar, V. K., Driver, R. J., Tataru, D., Paley, L., Marshall, A., et al. (2022). Regional variations in hepatocellular carcinoma incidence, routes to diagnosis, treatment, and survival in England. British journal of cancer, 126(5), 804–814. https://doi.org/10.1038/s41416-021-01509-4
  71. Cancer Research UK. Oesophageal cancer incidence statistics. Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/oesophageal-cancer/incidence#heading-One. Accessed November 2024
  72. Cancer Research UK (2023). Risks and causes of oesophageal cancer. Available at: https://www.cancerresearchuk.org/about-cancer/oesophageal-cancer/causes-risks
  73. Chen Q, Zhuang H, Liu Y. The association between obesity factor and esophageal cancer. J Gastrointest Oncol. 2012 Sep;3(3):226-31. https://doi.org/10.3978/j.issn.2078-6891.2012.026
  74. Cancer Research UK (2015). Liver cancer risk. Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/liver-cancer/risk-factors#heading-Eleven
  75. Johnston, A. J., Sivakumar, S., Zhou, Y., Funston, G., & Bradley, S. H. (2023). Improving early diagnosis of pancreatic cancer in symptomatic patients. The British journal of general practice: the journal of the Royal College of General Practitioners, 73(737), 534–535. https://doi.org/10.3399/bjgp23X735585
  76. Zakkak, N., Barclay, M. E., Swann, R., McPhail, S., Rubin, G., Abel, G. A., & Lyratzopoulos, G. (2024). The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit. British journal of cancer, 130(2), 297–307. https://doi.org/10.1038/s41416-023-02507-4
  77. Stapley, S., Peters, T. J., Neal, R. D., Rose, P. W., Walter, F. M., & Hamilton, W. (2013). The risk of oesophago-gastric cancer in symptomatic patients in primary care: a large case-control study using electronic records. British journal of cancer, 108(1), 25–31. https://doi.org/10.1038/bjc.2012.551
  78. Lloyd, T., Hounsome, L., Mehay, A., Mee, S., Verne, J., & Cooper, A. (2015). Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008-2010. BMC medicine, 13, 171. https://doi.org/10.1186/s12916-015-0405-5
  79. Zhou, Y., Singh, H., Hamilton, W., Archer, S., Tan, S., Brimicombe, J., et al. (2023). Improving the diagnostic process for patients with possible bladder and kidney cancer: a mixed-methods study to identify potential missed diagnostic opportunities. Br J Gen Pract. 73(733) 575-585. https://doi.org/10.3399/BJGP.2022.0602
  80. Zhou, Y., Walter, F.M., Singh, H., Hamilton, W., Abel, G.A., Lyratzopoulos, G. (2021). Prolonged diagnostic intervals as marker of missed diagnostic opportunities in bladder and kidney cancer patients with alarm features: A longitudinal linked data study. Cancers (Basel). 13(1):156. https://doi.org/10.3390/cancers13010156
  81. Zhou, Y., Lyratzopoulos, G., Rajan, P., Walter, FM., Wu, J. (2024). Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis. BJUI Compass.  5(7) 805–812. https://doi.org/10.1002/bco2.360
  82. Pearson, C., Poirier, V., Fitzgerald, K., Rubin, G., & Hamilton, W. (2020). Cross-sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms. BMJ open, 10(1), e033008. https://doi.org/10.1136/bmjopen-2019-033008
  83. Primary care direct access to CT of Chest/Abdomen/Pelvis (CAP) for patients with unidentified suspected malignancy https://www.nn.nhs.scot/scin/wp-content/uploads/sites/14/2023/04/Guidance-on-Direct-Access-to-CT-for-Primary-Care-Clinicians.pdf 
  84. Final report of the evaluation ofRapid Cancer Diagnostic Services – University of Strathclyde, December 2023 https://strathprints.strath.ac.uk/88280/7/Maguire-etal-2024-Final-report-of-the-evaluation-of-rapid-cancer-diagnostic-services.pdf 
  85. Smith, C. F., Tompson, A. C., Jones, N., Brewin, J., Spencer, E. A., Bankhead, C. R., et al. (2018). Direct access cancer testing in primary care: a systematic review of use and clinical outcomes. The British journal of general practice: the journal of the Royal College of General Practitioners, 68(674), e594–e603. https://doi.org/10.3399/bjgp18X698561
  86. Carrier, M., Lazo-Langner, A., Shivakumar, S., Tagalakis, V., Zarychanski, R., Solymoss, S., et al. (2015). Screening for occult cancer in unprovoked venous thromboembolism. The New England journal of medicine, 373(8), 697–704. https://doi.org/10.1056/NEJMoa1506623
  87. Children and young people with cancer in Scotland. Public Health Scotland. Children and young people with cancer in Scotland 9 May 2023 - Children and young people with cancer in Scotland - Publications - Public Health Scotland
  88. Herbert, A., Lyratzopoulos, G., Whelan, J., Taylor, R. M., Barber, J., Gibson, F., & Fern, L. A. (2018). Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohort. The Lancet. Child & adolescent health, 2(3), 180–190. https://doi.org/10.1016/S2352-4642(18)30004-X
  89. Liu, J. F., Shanmugavadivel, D., Ball-Gamble, A., Stewart, A., Walker, D., & Child Cancer Smart Awareness Campaign (2023). Public awareness of childhood, teenager and young adult cancer signs and symptoms in Great Britain: a cross-sectional survey. Archives of disease in childhood, 108(12), 987–993. https://doi.org/10.1136/archdischild-2023-325841
  90. Hart, R. I., Cowie, F. J., Jesudason, A. B., & Lawton, J. (2021). Adolescents and young adults' (AYA) views on their cancer knowledge prior to diagnosis: Findings from a qualitative study involving AYA receiving cancer care. Health expectations: an international journal of public participation in health care and health policy, 24(2), 307–316. https://doi.org/10.1111/hex.13170
  91. Children’s Cancer and Leukaemia Group (2023). Childhood Cancer: Care and Treatment. Information for GPs. Access here: Childhood_cancer_-_care_and_treatment_(GP)_2023.pdf (cclg.org.uk)
  92. Grace Kelly Trust - Childhood Cancer | Signs & Symptoms for Medical Professionals Accessed July 2025
  93. Referral guidance for suspected cancer in children and young people (2021). Guidelines | CCLG - The Children & Young People's Cancer Association
  94. Osteosarcoma - Symptoms, diagnosis and treatment | BMJ Best Practice https://bestpractice.bmj.com/topics/en-gb/780 Accessed February 2025